Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability

Drug Delivery

Volumn 17, Issue 3, 2010, Pages 114-122

  Wang, Wenyu ^a,b   Zhao, Xiuli ^a   Hu, Haiyang ^a   Chen, Dawei ^a   Gu, Jianchun ^a   Deng, Yihui ^a   Sun, Jin ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Institute of Materia Medica of Liaoning Province   (China)

Author keywords

Cucurbitacin B; Galactosylated lipid; Liver targetability; Solid lipid nanoparticles

Indexed keywords

CUCURBITACIN; CUCURBITACIN B; GALACTOSE; HEXADECYLAMINE LIPID; LACTOBIONIC ACID; LIPID; N HEXADECYL LACTOBIONAMIDE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG INDUSTRY; DRUG RELEASE; DRUG TARGETING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LASER DIFFRACTION; LIVER; LIVER PROTECTION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; ZETA POTENTIAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; CELL LINE, TUMOR; CELL SURVIVAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; GALACTOSE; INDICATORS AND REAGENTS; INJECTIONS, INTRAVENOUS; LIPIDS; LIVER; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION; TRITERPENES;

EID: 77949625163     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717540903580176     Document Type: Article

References (34)

1. Arangoa, M.A., Duzgunes, N., Tros de Ilarduy a, C., (2003). Increased receptor-mediated gene delivery to the liver by protamine enhanced asialofetuin lipoplexes. Gene Ther. 10:5-14.
2. Ashwell, G., Harford, J. (1982). Carbohydrate-specific receptors of liver. Annu Rev Biochem. 51:531-554
3. Bhadra, D., Yadav, A.K., Bhadra, S., Jain, N.K. (2005). Glycodendrimeric nanoparticlulate carriers of primaqurine phosphated for liver targeting. Int J Pharm. 295:221-233
4. Bundgaard, H. (1985). Formation of prodrugs of amines, amides,ureides and imides. Meth Enzymol. 112:347-359
5. Cavalli, R., Caputo, O., Gasco, M.R. (2000). Preparation and characterization of solid lipid nanospheres containing paclitaxel. Eur J Pharm Biopharm. 10:305-309
6. Cho, C.S., Cho, K.Y., Park, I.J., Kim, S.H., Sasagawa, T., Uchiyama, M., Akaike, T. (2001). Receptor-mediated delivery of all transretinoic acid to hepatocyte using poly (L-lactic acid) nanoparticles coated with galactose-carrying polystyrene. J Contr Rel. 77:7-15.
7. Choi, Y.H., Liu, F., Choi, J.S., Kim, S.W., Park, J.S. (1999). Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA. Hum Gene Ther. 10:2657-2665
8. de Vrueh, R.L.A., Rump, E.T., van de Bilt, E., van Veghel, R., Balzarini, J., Biessen, E.A.L., van Berkel, T.J.C., Bijsterbosch, M.K. (2000). Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl) adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B. Antimicrob Agents Chemother. 44:477-483
9. Gao, S., Chen, J., Xu, X., Ding, Z., Yang, Y.H., Hua, Z., Zhang, J. (2003). Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int J Pharm. 255:57-68.
10. Gupta, P.K., Hung, T. (1989). Quantitative evaluation of targeted drug delivery systems. Int J Pharm. 56:217-226
11. Han, J., Lim, S.J., Lee, M.K., Kim, C.K. (2001). Altered pharmacokinetics and liver targetability of methotrexate by conjugation with lactosylated albumins. Drug Deliv 8:125-134
12. Hashida, M., Akamatsu, K., Nishikava, M., Yamashita, F., Takakura, Y. (1999). Design of polymeric prodrugs of prostaglandin E-1 having galactose residue for hepatocyte targeting. J Contr Rel. 62:253-262
13. Heurtault, B., Saulnier, P., Pech, B. (2003). Physico-chemical stability of colloidal lipid particles. Biomaterials. 24:4283-4300
14. Ishida, E., Managit, C., Kawakami, S., Nishijawa, M., Yamashita, F., Hashida. M. (2004). Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyteselective targeting of lipophilic drugs in mice. Pharm Res. 21:932-939
15. Kassab, R., Parrot-Lopez, H., Fessi, H., Menaucourt, J., Bonaly, R., Coulon. J. (2002). Molecular recognition by Kluyveromyces of amphotericin B-loaded, galactose-tagged, poly (lactic acid) microspheres. Bioorg Med Chem. 10:1767-1775
16. Kawakami, S., Wong, J., Sato, A., Hattori, Y., Yamashita, F., Hashida, M. (2000). Biodistribution characteristics of mannosylated, fucosylated,and galactosylated liposomes in mice. Biochim Biophys Acta. 1524:258-265
17. Kim, C.K.,Min, M.H., Min, K.H., Lah, W.Y., Lee, B.J., Kim, Y.B. (1992). Synthesis of N-stearyl lactobionamide (NSLBA) and preparation of neo-galactosylated liposome. Yakhak Hoej. 36:159-166
18. Kiwada, H., Kato, Y. (1985). Tissue distribution and pharmacokinetic evaluation of the targeting efficiency of synthetic glycoside vesicles. Chem Pharm Bull. 33:2475-2482
19. Li, C.Y., Hou, S.X., Yang, K., Mao, S.J. (2001). Study on quantitative determination of cucurbitacins B in plasma by HPLC. Chin Pharm J. 36:557-559
20. Liu, T.Y., Zhang, M.X., Zhang, H.L., Sun, C.Y., Yang, X.L., Deng, Y.H., Ji, W.Y. (2008). Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer. Eur J Pharmcol. 587:78-84.
21. Lu, W., He, L.C., Wang, C.H., Li, Y.H., Zhang, S.Q. (2008). The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice. Int J Biol Macromol. 43:320-324
22. Molavi, O., Ma, Z.S., Mahmud, A., Alshamsan, A., Samuel, J., Lai, R., Kwon, G., Lavasanifar, A. (2008). Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int J Pharm. 347:118-127
23. Müller, R.H., Madar, K., Gohla, S. (2000). Solid lipid nanoparticles (SLNs) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm. 0: 161-177
24. Müller, R.H., Mehnert, W., Lucks, J.S., Schwarz, C., Zur Muhlen, A., Weyhers, H., Freitas, C., Ruhl, D. (1995). Solid lipid nanoparticles (SLNs)-an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm. 41:62-69
25. Nag, A., Ghosh, P.C. (1999). Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver. J Drug Target. 6:427-438
26. Ney, P. (1973). Zetapotentiale and flotierbarkeit von mineralien. New York: Springer.
27. Orr, G.A., Rando, R.R., Bangerter, F.W. (1979). Synthetic glycolipids and the lectin-mediated aggregation of liposomes. J Biol Chem. 254:4721-4725
28. Park, I.K., Kim, T.H., Park, Y.H., Shin, B.A., Choi, E.S., Chowdhury, E.H., Akaike, T., Cho, C.S. (2001). Galatosylated chitosan-graftpoly (ethylene glycol) as hepatocyte-targeting DNA carrier. J Contr Rel. 76:349-362
29. Ren, F.B., Hong, M. (1986). Cucurbitacins in the treatment of hepatitis and primary liver cancer: current status of pharmacological and clinical research. Chin J Integ Trad West Med. 6:633-635
30. Sliedregt, L.A.J.M., Rensen, P.C.N., Rump, E.T., van Santbrink, P.J., Bijsterbosch, M.K., Valentijn, A.R.P.M., van der Marel, G.A., van Boom, J.H., van Berkel, T.J.C., Biesen, E.A.L. (1999). Design and synthesis of novel amphiphilic dendritic galactoside for selective targeting of liposomes to the hepatic asialoglycoprotein receptor. J Med Chem. 42:609-618
31. Williams, T.J., Plessas, N.R., Goldstein, L.J. (1978). Synthesis of a new class of model glycolipids. Carbohyd Res. 67:C1-3.
32. Williams, T.J., Plessas, N.R., Goldstein, I.J. (1979). A new class of model glycolipids: synthesis, characterisation and interaction with lectins. Arch Biochem Biophys. 195:145-151
33. Wu, J., Nantz, M.H., Zern, M.A. (2002). Targeting hepatocytes for drug and gene delivery: emerging novel approaches and application. Front Biosci. 7:17-25.
34. Yamamoto, M., Ichinose, K., Ishii, N., Khoji, T., Akiyoshi, K., Moriguchi, N., Sunanoto, J., Kanematsu, T. (2000). Utility of liposomes coated with polysaccharide bearing 1-amino-lactose as targeting chemotherapy for AH66 hepatoma cells. Oncol Rep. 7:107-111